How are CE Methods Being Adapted to Analyze New Biopharmaceutical Drug Modalities?
August 15th 2020The increase in non-monoclonal antibody protein drug candidates has required researchers to develop new methods. By adapting existing approaches find out how Dr. Stephen Lock is answering this challenge to better profile these extremely complex proteins. Wednesday, Sept. 2, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing until Sept. 2, 2021.
Access Monoclonal Antibody Quality Attributes with HRMS Analytical Power
December 5th 2019In the webcast, learn how using a high-resolution mass spectrometry-based approach can be a powerful analytical strategy to monitor and define multiple critical quality attributes (multi-attribute monitoring) of complex biomolecules in a single assay using a single instrument platform. Live: Thursday, Dec. 5, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET On demand available after final airing until Dec. 5, 2020 Register free